Label for prefilled syringes provides prick protection

Schreiner MediPharm's Needle-Trap technology has been used successfully by PfizerPfizer has selected Schreiner MediPharm’s Needle-Trap label for its epoetin biosimilar prefilled syringes. This is the first medication developed to treat anaemia that has been launched with Needle-Trap, initially in Germany and Austria, and later rolled out in the wider European market.

Pharma giant Pfizer develops innovative medicines, vaccines and over the counter products. The company needed a reliable solution to protect healthcare personnel from needle stick injuries when administering the epoetin biosimilar injection. Since 2009, Schreiner MediPharm's Needle-Trap technology has been used successfully by Pfizer on millions of syringes for a heparin drug.

Needle-Trap features a unique design, which is easily integrated into existing pharma manufacturing processes. The plastic needle trap is an integral component of the label for prefilled syringes. With a simple and irreversible trigger, Needle-Trap serves to secure the needle after injecting, protecting the healthcare professional. It doesn’t require any changes to the injection technique as the needle protection is integrated into the syringe label. 

No adaptations are needed to the secondary packaging and it uses minimal space during shipping, storage and disposal.

 


Subscribe to our mailing list

* indicates required

Would you like to receive our FREE e-newsletter?

* indicates required
Close